Genome-wide CRISPR and shRNA screening demonstrated that knockout of CDK4 or CDK6 inhibited neuroblastoma cell proliferation/survival while Rb1 knockout promoted cell proliferation (https://depmap.org/portal/). The gene discussed is CDK4; the disease is neuroblastoma.